Citadel Group Ltd reports: Is it a buy at this share price?

Here's why the Citadel Group Ltd (ASX:CGL) share price is lower today.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Citadel Group Ltd (ASX: CGL) share price traded 2% lower today following the release of the IT services company's half-year report. Here are the key takeaways.

  • Revenue from continuing operations up 6.4% to $44.1 million
  • Revenue down 3.5% to $46 million
  • Net profit after tax (NPAT) from continuing operations attributable to members up 9.4% to $5 million
  • NPAT attributable to members down 33.8% to $3.7 million
  • Earnings-per-share (EPS) from continuing operations attributable to members up 8% to 10.7 cents
  • 8 cent fully-franked interim dividend down from 5.8 cents last year

During the period, Citadel divested its vocational training subsidiary, Australian Business Academy Pty Ltd, due to adverse regulatory changes impacting profitability. Profits from continuing operations exclude the loss from this business and so are a more relevant indication of business performance as opposed to overall profits.

However, the crucial number for assessing Citadel's performance is EPS from continuing operations attributable to members. Not only does this exclude the impact of Australian Business Academy Pty Ltd, but it also filters out group profits which are not attributable to shareholders. Furthermore, it accounts for a roughly $5 million increase in shareholder equity used to partially pay for Kapish Pty Ltd and Kapish Services Pty Ltd ("Kapish") which Citadel acquired on 1 July 2016.

It is important to note that only profits attributable to shareholders are relevant. Citadel recorded NPAT attributable to non-controlling interests of $1.7 million in the half compared to nothing last year and this should be excluded to understand Citadel's underlying business performance.

The amount relates to filosoph-e Pty Ltd which became a subsidiary of the group on 1 April 2016 after Citadel acquired a further 25% interest, taking Citadel's total ownership to 50%. The $1.7 million effectively represents the 50% of filosoph-e profits that do not belong to Citadel.

All things being equal you would expect that an additional 25% contribution from filosoph-e Pty Ltd and almost a full-period contribution from Kapish would have boosted Citadel's NPAT.

Indeed in the notes to the accounts it states: "Included in the profit after tax for the half-year is $1.7 million attributable to the additional business generated by Kapish (2015: Nil)."

Whilst group NPAT from continuing operations and attributable to members was higher, it was only modestly up 9.4% or $0.4 million and so organic profits went backwards by at least $1 million.

Citadel's balance sheet deteriorated during the half, thanks largely to cash payments for acquisitions totalling $20.4 million. Cash after adjusting for debt fell from $33.3 million at 30 June 2016 to $8.7 million at 31 December 2016.

Foolish takeaway

Citadel delivers large multi-year contracts primarily to the public sector and so profits can be lumpy. Therefore, if organic profits fell compared to the prior period this does not necessarily indicate that the business is struggling. On the other hand, perhaps the decision of the board to reduce dividends hints to the contrary.

The stock trades on a historical price-to-earnings ratio (PER) of 29 which to me seems like a lot for this type of business. I have owned Citadel previously but sold when the company's full-year 2016 results came in way below my expectations. That meant that the stock was priced far more expensively than I had previously thought and based on today's report it still looks too expensive in my opinion.

Motley Fool contributor Matt Brazier has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »